NCT07360132 2026-01-22Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung CancerShanghai Huaota Biopharmaceutical Co., Ltd.Phase 3 Not yet recruiting480 enrolled